Metraipolis › archive › dc_a3d70a2efbe6

Prospective SARS-CoV-2 additional vaccination in immunosuppressant-treated individuals with autoimmune diseases in a randomized controlled trial — Europe PMC PMID:41289027

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41289027
DOI
10.1172/jci.insight.191266
License (as archived)
solo-consultazione
Archived
2026-11-08T06:32:52.363Z
SHA-256 of the archived text
c1e682065997ecf1572fe4b5e20f4a411634464980ccae04fd25f3ad181e37e4
Stable URL of this page
https://metraipolis.com/documento/dc_a3d70a2efbe6

How to cite

Prospective SARS-CoV-2 additional vaccination in immunosuppressant-treated individuals with autoimmune diseases in a randomized controlled trial — Europe PMC PMID:41289027 — Europe PMC (en), https://europepmc.org/article/MED/41289027 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a3d70a2efbe6 (Metraipolis archive dc_a3d70a2efbe6, sha256 c1e682065997ecf1572fe4b5e20f4a411634464980ccae04fd25f3ad181e37e4)
BibTeX
@misc{dca3d70a2efbe6,
  title = {Prospective SARS-CoV-2 additional vaccination in immunosuppressant-treated individuals with autoimmune diseases in a randomized controlled trial — Europe PMC PMID:41289027},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41289027},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a3d70a2efbe6; sha256 c1e682065997ecf1572fe4b5e20f4a411634464980ccae04fd25f3ad181e37e4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41289027. Agents can read the archived copy with the MCP tool read_document.